Health Care & Life Sciences » Biotechnology | Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.62
Market Cap
$914.38 M
Shares Outstanding
46.32 M
Public Float
38.75 M

Profile

Address
611 Gateway Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.atarabio.com
Updated 07/08/2019
Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E.

Financials

View All

Issac E. Ciechanover
Chairman, President & Chief Executive Officer
William K. Heiden
Director